![]() Schwartz led two new clinical trials testing the use of stem cell-derived retinal pigment epithelial cells to address vision loss in people suffering from Stargardt's macular dystrophy and dry age-related macular degeneration. Schwartz is dedicated to improving both the quality of and access to specialized ophthalmology care. Through innovative teleophthalmological approaches to screen for eye diseases (such as diabetic retinopathy and ROP), Dr. Schwartz’ clinical research focuses on trials of novel pharmacotherapeutic agents to discover treatments for both wet and dry age-related macular degeneration, ROP, and diabetic retinopathy. Schwartz also takes an entertaining look at his career, the many start-ups that he’s had a hand in, and the future of surgical robotics. Physical Chemistry Seminar, Seminars When: Janu4:00 pm Where: Young Hall 2033 Speaker: Steven Schwartz Description Rare Event Sampling, Protein Dynamics in enzymatic catalysis and directed evolution: lessons in artificial enzyme design. Additionally, his focus includes development and evaluation of novel medical device technologies, imaging technologies, surgical equipment (including surgical robots), and drug delivery systems, with particular emphasis on diagnostic and treatment applications. Schwartz’ primary areas of research include early diagnosis and treatment of diseases such as macular degeneration, retinopathy of prematurity (ROP), and diabetic eye disease. David Geffen School of Medicine at UCLAĭr.We’d love to hear from you! Send your comments/questions to Follow John Hovanesian on Twitter You can reach Dr.Professional Affiliations Academic Appointments Jim Mazzo sits on numerous ophthalmic industry corporate boards and committees after serving in executive roles with Allergan, Avellino Labs, Carl Zeiss and AMO. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. ![]() Schwartz, MD, is the Ahmanson professor in ophthalmology and the chief of the retina division at the UCLA Jules Stein Eye Institute and the director of the Diabetic Eye Disease and Retinal Vascular Center.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |